세계의 의약품 분야 인공지능(AI) 시장 : 전개 방식별, 제공별, 기술별, 약물 유형별, 용도별, 최종사용자별, 지역별

Global Artificial Intelligence (AI) In Pharmaceutical Market, By Deployment Mode, By Offering, By Technology, By Drug Type, By Application, By End User, By Geography

US $ 4,500 ￦ 6,277,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,000 ￦ 9,764,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,949,000

PDF (Enterprise User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

의약품 분야 인공지능(AI) 세계 시장 규모는 2025년 14억 6,610만 달러로 추정되며, 2032년에는 104억 690만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 연평균(CAGR) 32.3%로 성장할 것으로 예상됩니다.

보고서 범위		보고서 상세
기준 연도	2024년	2025년 시장 규모	14억 6,610만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간 : 2025-2032년 CAGR	32.30	2032년 가치 예측	104억 690만 달러

인공지능(AI)은 제약 업계에 혁명을 불러일으킬 혁신 기술로 등장했습니다. AI는 방대한 데이터와 정교한 알고리즘을 활용하여 제약회사들이 신약개발을 가속화하고, 임상시험을 간소화하며, 보다 정확한 진단과 치료를 가능하게 할 수 있는 잠재력을 가지고 있습니다. AI를 통해 연구자들은 전례 없는 규모와 속도로 유전자 염기서열 정보와 전자 의료 기록을 분석할 수 있습니다. 이 기술은 새로운 치료법을 발견하고 기존 약물을 다른 질병 치료에 재사용할 수 있는 가능성을 예측하는 데 도움을 주며, AI는 인간의 능력을 확장하고 제약 연구 개발의 효율성을 높이며 혁신적인 신약을 환자에게 더 빨리 전달할 수 있도록 도와줄 것입니다.

시장 역학:

인공지능(AI) 시장의 성장은 신약 개발 비용 절감, 신약 개발 주기 단축, 정밀의료 발전에 대한 수요 증가에 힘입어 세계 제약 업계의 인공지능(AI) 시장 성장의 원동력이 되고 있으며, AI는 신약 개발을 가속화하고, 값비싼 후기 임상시험 실패를 줄이고, 의약품의 조기 출시에 기여할 수 있습니다. 그러나 AI 모델의 해석 가능성 부족과 의사결정에의 통합에 대한 회의적인 시각은 AI의 채택을 방해할 수 있습니다. 제약 데이터세트의 가용성이 증가하고 규제 프레임워크가 강화되면 큰 성장 기회를 제공할 수 있습니다. 적절히 대처하면 해석 가능성 문제와 전문성 부족을 극복하고 이 혁신적인 기술의 잠재력을 극대화할 수 있습니다.

본 조사의 주요 특징

• 세계의 의약품 분야 인공지능(AI) 시장을 상세히 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 연평균 성장률(CAGR)을 조사 분석하여 전해드립니다.
• 다양한 부문에 걸친 잠재적 수익 창출 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 인사이트를 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 의약품 분야 인공지능(AI) 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 제약 분야의 세계 인공지능(AI) 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 의약품 분야 인공지능(AI) 세계 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 가정

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 주요 발전
• 규제 시나리오
• 인수와 제휴 시나리오
• 자금 조달과 투자
• PEST 분석
• Porters 분석

제4장 세계의 의약품 분야 인공지능(AI) 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 이니셔티브
• COVID-19의 시장에 대한 영향

제5장 세계의 의약품 분야 인공지능(AI) 시장, 전개 방식별, 2021-2032년

• 클라우드
• 온프레미스

제6장 세계의 의약품 분야 인공지능(AI) 시장, 제공별, 2021-2032년

• 하드웨어
• 소프트웨어
• 서비스

제7장 세계의 의약품 분야 인공지능(AI) 시장, 기술별, 2021-2032년

• 자연어 처리
• 상황 인식 처리
• 딥러닝
• 쿼리 방법
• 기타

제8장 세계의 의약품 분야 인공지능(AI) 시장, 약물 유형별, 2021-2032년

• 거대 분자
• 소분자

제9장 세계의 의약품 분야 인공지능(AI) 시장, 용도별, 2021-2032년

• Drug Discovery
• 임상시험
• 연구개발
• 의약품 제조 및 공급망
• 기타

제10장 세계의 의약품 분야 인공지능(AI) 시장, 최종사용자별, 2021-2032년

• 제약·바이오테크놀러지 기업
• 병원과 진단 센터
• 학술연구기관
• 기타

제11장 세계의 의약품 분야 인공지능(AI) 시장, 지역별, 2021-2032년

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제12장 경쟁 구도

• 기업 개요
  • NVIDIA Corporation
  • IBM Corporation
  • Exscientia
  • Insilico Medicine
  • Atomwise, Inc.
  • Cloud Pharmaceuticals, Inc.
  • Cyclica Inc.
  • Envisagenics, Inc.
  • Numerate, Inc.
  • Schrodinger, Inc.
  • Standigm
  • Turbine.ai
  • BenevolentAI
  • Recursion Pharmaceuticals
  • Owkin, Inc.
  • XtalPi Inc.
  • Valo Health
  • Absci

제13장 애널리스트의 추천사항

• Wheel of Fortune
• 애널리스트의 견해
• Coherent Opportunity Map

제14장 참고문헌과 조사 방법

• 참고문헌
• 조사 방법

ksm

영문 목차

영문목차

Global Artificial Intelligence (AI) In Pharmaceutical Market is estimated to be valued at USD 1,466.1 Mn in 2025 and is expected to reach USD 10,406.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 32.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 1,466.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	32.30%	2032 Value Projection:	USD 10,406.9 Mn

Artificial intelligence (AI) has emerged as a transformative technology that is poised to revolutionize the pharmaceutical industry. By leveraging huge amounts of data and sophisticated algorithms, AI has the potential to help drug makers to accelerate drug discovery, streamline clinical trials and enable more precise diagnosis and treatment. AI augments the work of pharmaceutical scientists by swiftly analyzing huge datasets to identify relationships that may lead to new therapies. With AI, researchers can analyze genetic sequencing information or electronic health records at an unprecedented scale and speed. The technology helps discover new therapies and predict which existing drugs could be repurposed to treat other conditions. AI promises to augment human capabilities, make pharmaceutical R&D more efficient and bring innovative new medicines to patients faster.

Market Dynamics:

Global artificial intelligence (AI) in pharmaceutical market growth is driven by rising need to control drug discovery and development costs, reduce the drug development cycle time and advance precision medicine. AI can accelerate drug discovery, reduce expensive late-stage clinical trial failures and help launch drugs faster. However, lack of interpretability of AI models and skepticism about integrating it into decision-making can hamper its adoption. Growing availability of pharma data sets and encouraging regulatory frameworks can offer significant growth opportunities. If addressed properly, interpretability issues and lack of expertise can be overcome to extract full potential from this transformative technology.

Key Features of the Study:

• This report provides in-depth analysis of the global artificial intelligence (AI) in pharmaceutical market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global artificial intelligence (AI) in pharmaceutical market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include IBM, Microsoft, AWS, Google, Anthropic, Berg Health and InSilico Medicine
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global artificial intelligence (AI) in pharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (AI) in pharmaceutical market

Detailed Segmentation-

• By Deployment Mode
  • Cloud
  • On-Premise
• By Offering
  • Hardware
  • Software
  • Services
• By Technology
  • Natural Language Processing
  • Context-Aware Processing
  • Deep Learning
  • Querying Method
  • Other
• By Drug Type
  • Large Molecules
  • Small Molecules
• By Application
  • Drug Discovery
  • Clinical Trial
  • Research & Development
  • Drug Manufacturing and Supply Chain
  • Others
• By End User
  • Pharmaceutical & Biotechnology Companies
  • Hospitals and Diagnostic Centers
  • Academic & Research Institutes
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • NVIDIA Corporation
  • IBM Corporation
  • Exscientia
  • Insilico Medicine
  • Atomwise, Inc.
  • Cloud Pharmaceuticals, Inc.
  • Cyclica Inc.
  • Envisagenics, Inc.
  • Numerate, Inc.
  • Schrodinger, Inc.
  • Standigm
  • ai
  • BenevolentAI
  • Recursion Pharmaceuticals
  • Owkin, Inc.
  • XtalPi Inc.
  • Valo Health
  • Absci

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Deployment Mode
  • Market Snapshot, By Offering
  • Market Snapshot, By Technology
  • Market Snapshot, By Drug Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Artificial Intelligence (AI) in Pharmaceutical Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Deployment Mode, 2021 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cloud
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• On-Premise
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Offering, 2021 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hardware
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Software
  • Mammography
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Services
  • Chest X-ray
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Technology, 2021 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Natural Language Processing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Context-Aware Processing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Deep Learning
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Querying Method
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Drug Type, 2021 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Large Molecules
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Small Molecules
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Application, 2021 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Drug Discovery
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Clinical Trial
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Research & Development
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Drug Manufacturing and Supply Chain
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

10. Global Artificial Intelligence (AI) in Pharmaceutical Market, By End User, 2021 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical & Biotechnology Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Hospitals and Diagnostic Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Academic & Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

11. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Region, 2021 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2032, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

12. Competitive Landscape

• Company Profiles
  • NVIDIA Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • IBM Corporation
  • Exscientia
  • Insilico Medicine
  • Atomwise, Inc.
  • Cloud Pharmaceuticals, Inc.
  • Cyclica Inc.
  • Envisagenics, Inc.
  • Numerate, Inc.
  • Schrodinger, Inc.
  • Standigm
  • Turbine.ai
  • BenevolentAI
  • Recursion Pharmaceuticals
  • Owkin, Inc.
  • XtalPi Inc.
  • Valo Health
  • Absci

13. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

14. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

관련자료